IPV-102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPV-102, covering 2020-01-31 to 2020-01-31. Get the full timeline:
Most recent: Clinical Trial Update: IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults [Phase 1, Phase 2]